You are here

R&D

J&J, Merck and Pfizer spent tax savings on investor payouts, not R&D: Oxfam

Fierce Pharma

Mon, 04/15/19 - 11:30 am

UK R&D Roundup: Pharma gets in on the biotech boom

Pharmaforum

Sun, 04/14/19 - 04:10 pm

Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut

Fierce Pharma

Thu, 04/11/19 - 12:27 pm

Bristol-Myers Squibb

Ono Pharmaceutical

Regeneron, Alnylam spell out a research alliance that could run beyond a decade, with billions built in for success

Endpoints

Thu, 04/11/19 - 10:11 am

After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT

Endpoints

Tue, 04/9/19 - 08:29 am

What causes immuno-oncology drug resistance? 2 research teams uncover clues

Fierce Biotech

Fri, 04/5/19 - 10:32 am

immuno-oncology

checkpoint inhibitors

GSK adds to COPD pipeline as Exscientia deal bears fruit

Pharmaforum

Fri, 04/5/19 - 10:31 am

artificial intelligence

Lonza launches joint venture to supply microbiome field

Biopharma Dive

Wed, 04/3/19 - 09:32 pm

Xencor, Astellas Pharma collaborate on novel bispecific antibody program

Pharmaceutical Business Review

Wed, 04/3/19 - 10:00 am

bispecific antibodies

What a new FDA commissioner could mean for clinical research

Mass Device

Tue, 04/2/19 - 11:29 pm

Small biotech the ‘true engine’ of antibiotic innovation, as pharma ‘spews nonsense’ on its R&D: Jim O'Neill

Fierce Biotech

Sat, 03/30/19 - 01:07 pm

antibiotic resistance

AstraZeneca to help build new life science research cluster in China

Fierce Biotech

Thu, 03/28/19 - 11:38 am

1 Surprising Reason Alzheimer's Drugs Remain So Elusive

Motley Fool

Mon, 03/25/19 - 10:13 pm

Alzheimer's disease

drug development

Inflazome grabs Fox Foundation funding for Parkinson’s R&D

Fierce Biotech

Mon, 03/25/19 - 10:26 am

Parkinson's Disease

How Will The Failure Of Biogen's Alzheimer's Drug, Aducanumab, Impact R&D?

Forbes

Fri, 03/22/19 - 10:22 am

Alzheimer's disease

UK biotech industry booms on record investment – analysis

Pharmaforum

Thu, 03/21/19 - 09:39 am

Alexion adds to pipeline with two early-stage R&D deals

BioPharma Dive

Wed, 03/20/19 - 12:25 pm

Alexion Pharmaceuticals

Merck doubles down on NGM Bio pact but culls obesity drug

Fierce Biotech

Wed, 03/20/19 - 12:15 pm

NGM Biopharmaceuticals

WHO panel pushes for genome editing research registry

Fierce Biotech

Wed, 03/20/19 - 12:12 pm

Life Science Research Provider Files for $100 Million IPO

CP WIre

Mon, 03/18/19 - 10:25 am

Pages